Alyeska Investment Group’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,406
Closed -$573K 504
2019
Q4
$573K Buy
+7,406
New +$523K 0.01% 350
2018
Q1
Sell
-1,547,618
Closed -$90.5M 531
2017
Q4
$90.5M Sell
1,547,618
-12,322
-0.8% -$699K 0.72% 45
2017
Q3
$86.5M Buy
1,559,940
+187,863
+14% +$12.4M 0.65% 43
2017
Q2
$106M Buy
1,372,077
+766,511
+127% +$57.3M 0.88% 24
2017
Q1
$45.2M Sell
605,566
-292,489
-33% -$21.2M 0.37% 96
2016
Q4
$60.5M Buy
898,055
+162,233
+22% +$10.5M 0.5% 54
2016
Q3
$49M Sell
735,822
-223,207
-23% -$14.2M 0.45% 64
2016
Q2
$57.3M Sell
959,029
-64,138
-6% -$3.47M 0.54% 50
2016
Q1
$49.8M Sell
1,023,167
-240,192
-19% -$10.9M 0.46% 73
2015
Q4
$68.4M Buy
1,263,359
+2,688
+0.2% +$137K 0.73% 36
2015
Q3
$60.8M Buy
1,260,671
+437,961
+53% +$22.6M 0.71% 37
2015
Q2
$39M Buy
+822,710
New +$38.5M 0.44% 76

Other funds holding NUVA

Alyeska Investment Group's NUVA Position: Q1 2020 in Review

Alyeska Investment Group sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 7,406 shares — an estimated $573K sold.

Alyeska Investment Group first reported a position in NUVA in Q2 2015 and held it in 12 quarters. The position peaked at $106M in Q2 2017. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

  • Alyeska Investment Group reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 7,406 NuVasive, Inc. shares in Q1 2020, an estimated $573K.
  • Alyeska Investment Group first reported a position in NuVasive, Inc. in Q2 2015 and held it in 12 quarters.
  • Alyeska Investment Group's NuVasive, Inc. position peaked at $106M in Q2 2017.
  • 266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.